GCM
BSX icon

Glenview Capital Management’s Boston Scientific BSX Stock Holding History

Glenview Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Buy
+113,096
New +$6.14M 0.09% 43
2022
Q4 		– Sell
-167,213
Closed -$6.48M – 56
2022
Q3 		$6.48M Sell
167,213
-728,183
-81% -$29.2M 0.16% 48
2022
Q2 		$33.4M Sell
895,396
-489,233
-35% -$19.9M 0.83% 28
2022
Q1 		$61.3M Buy
1,384,629
+285,945
+26% +$12.4M 1.24% 24
2021
Q4 		$46.7M Sell
1,098,684
-964,613
-47% -$40.5M 0.99% 31
2021
Q3 		$89.5M Sell
2,063,297
-259,719
-11% -$11.5M 1.62% 22
2021
Q2 		$99.3M Sell
2,323,016
-874,950
-27% -$36.8M 1.64% 18
2021
Q1 		$124M Buy
3,197,966
+495,085
+18% +$18.7M 2.09% 13
2020
Q4 		$97.2M Buy
2,702,881
+1,657,829
+159% +$59.8M 2.23% 11
2020
Q3 		$39.9M Sell
1,045,052
-1,067,949
-51% -$41.2M 1.25% 19
2020
Q2 		$74.2M Sell
2,113,001
-274,858
-12% -$9.9M 2.05% 16
2020
Q1 		$77.9M Buy
+2,387,859
New +$93.3M 2.12% 17

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Glenview Capital Management's BSX Position: Q2 2026 in Review

Glenview Capital Management opened a new position in Boston Scientific (BSX) in Q2 2026: 113,096 shares worth $4.83M. The stake represents 0.09% of the portfolio and ranks #43 among its holdings. This is a return to the name: Glenview Capital Management previously reported a position in BSX as recently as Q3 2022.

Glenview Capital Management first reported a position in BSX in Q1 2020 and has held it in 12 quarters since. The position peaked at $124M in Q1 2021. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Glenview Capital Management held 113,096 shares of Boston Scientific worth $4.83M as of Q2 2026.
  • Boston Scientific was a new Glenview Capital Management position in Q2 2026.
  • Boston Scientific made up 0.09% of Glenview Capital Management's portfolio in Q2 2026, its #43 holding.
  • Glenview Capital Management first reported a position in Boston Scientific in Q1 2020 and has held it in 12 quarters since.
  • Glenview Capital Management's Boston Scientific position peaked at $124M in Q1 2021.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.